Webinar | N-Glycan Characterization: Future of mAb Standardization
About this event
In this Protein Metrics webinar to discover critical insights into glycan analysis, impact on therapeutics, and standardization approaches for safer, more effective treatments. Webinar | N-Glycan Characterization: Future of mAb Standardization is an official webinar listing associated with Dotmatics.
Visit the company-owned event page for the organizer's latest agenda, access details, availability, and registration or viewing instructions. UPCOMING provides this independent listing to help professionals discover the session.
What you'll learn
- Comparison of innovator anti-TNF⍺ mAbs (Humira®, Remicade®, Simponi Aria®) and trastuzumab biosimilars (Kanjinti®, Ogivri®) with reference drugs.
- Highlighting the impact of glycan differences in mAbs on patient experience.
- Suggesting future standardization approaches for glycan characterization in mAbs.
Topics covered
Frequently asked questions
Who is hosting Webinar | N-Glycan Characterization: Future of mAb Standardization?
Webinar | N-Glycan Characterization: Future of mAb Standardization is hosted by Dotmatics.
When is Webinar | N-Glycan Characterization: Future of mAb Standardization?
Webinar | N-Glycan Characterization: Future of mAb Standardization is scheduled for Wednesday, March 6, 2024.
Where does registration take place?
Registration or viewing is completed on Dotmatics's website.
What format is this event?
This is an online webinar.
Which topics does this event cover?
The event covers Data.
More from Dotmatics
View all →EndedMay 14, 2025
What’s New in ELN & Data Discovery 7.3: Delivering More Integrated, Insight-Driven Science
Dotmatics
EndedDec 18, 2024
Streamline Flow Cytometry Data with Luma-OMIQ Integration: Join Experts from Dotmatics
Dotmatics
EndedOct 29, 2024
Streamline Flow Cytometry Data with Luma-OMIQ Integration: Join Experts from Dotmatics
Dotmatics